Pharmacy News and Research

RSS

Community pharmacy, also known as retail pharmacy, is the most common type of pharmacy that allows the public access to their medications and advice about their health. Traditionally known as a chemist, it is the healthcare facility that is responsible for the provision of pharmaceutical service to a specific community group or region.

New wearable patch may provide improved treatment experience for melanoma patients

Conventional melanoma therapies, including chemotherapy and radiotherapy, suffer from the toxicity and side effects of repeated treatments due to the aggressive and recurrent nature of melanoma cells.

16 Jun 2020

Apotex recalls some Metformin batches due to possible carcinogen

Metformin, a prescription drug for people with type II diabetes, helps maintain blood glucose levels. Apotex Inc., a Canadian pharmaceutical corporation, is voluntarily recalling some batches of its metformin drug, sold under the brand name APO-Metformin ER (extended-release).

15 Jun 2020

Study finds link between high levels of dietary AGEs and breast cancer risk

Hollings Cancer Center researchers at the Medical University of South Carolina and colleagues assessed the connection between dietary advanced glycation end products and breast cancer risk in a study first published online March 2020 in Cancer Prevention Research.

12 Jun 2020

Human cardiac organoids for modeling physiological conditions during a heart attack

In the U.S., someone has a heart attack every 40 seconds, and yet researchers have not had a model that fully mimics what occurs in the human heart after a heart attack.

12 Jun 2020

COVID-19 batters a beloved Bay Area community health care center

A small band of volunteers started the Marin City Health and Wellness Center nearly two decades ago with a doctor and a retired social worker making house calls in public housing high-rises.

12 Jun 2020

Drug-like molecules offer a promising treatment for COVID-19

A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein - providing a promising path for new COVID-19 therapeutics.

12 Jun 2020

Pharmacy experts warn about sub-standard hand sanitizers

An international team of pharmacy experts has researched the effectiveness of hand sanitizers in the fight against CoViD-19 and warned the public to beware of sub-standard products.

12 Jun 2020

Using nanotheranostics approach to treat cancer

The concept of theranostics revolves around the stratification of patients into specific groups based on their response to different treatments and their disease risks.

10 Jun 2020

Age-related structural brain changes are linked to hormone-level changes

Sex hormones influence the structure and function of the brain, but little is known about the effect of hormone therapies (HT) on changes in the brain during menopause.

10 Jun 2020

Health disparities negatively impact various groups of people

Certain illnesses and diseases have the ability to affect various groups of people in detrimental ways.

8 Jun 2020

Pharmacists involved in cancer care face restricted access to essential PPE items

Oncology pharmacy practitioners around the globe are fighting to provide cancer patients high quality cancer care with increasingly limited and sometimes restricted personal protective equipment supply as well as impaired access to essential anticancer medication, according to University of California, Irvine-led study.

8 Jun 2020

MUSC receives $16.5 million NIH funding to open two new digestive disease research centers

This spring marked a seismic shift for digestive and liver disease research at the Medical University of South Carolina with the award of more than $16.5 million in National Institutes of Health funding to open two new tightly integrated centers.

5 Jun 2020

UTHSC researchers receive NIH award for opioid addiction studies

A team of University of Tennessee Health Science Center researchers in the College of Medicine recently received a National Institutes of Health award to study how genetic differences may explain why some people are more susceptible to opioid addiction than others.

5 Jun 2020

Researchers investigate new approaches to treating neurodegenerative diseases

Heidelberg researchers investigate new approaches to treating neurodegenerative diseases. Protecting nerve cells from losing their characteristic extensions, the dendrites, can reduce brain damage after a stroke.

5 Jun 2020

A roadmap to help older Britons struggling with 'shopping lists' of medication

New research provides a roadmap to help the millions of older Britons struggling with 'shopping lists' of medication, as fears grow that the current coronavirus lockdown could be further isolating the most vulnerable.

5 Jun 2020

Newly identified mechanism regulates activity of nitric oxide-producing enzyme

The liver filters blood, detoxifies chemicals and metabolizes drugs. Hepatitis, alcohol and primary liver diseases are common sources of damage in the liver and can result in scarring, known as fibrosis.

5 Jun 2020

Hydroxychloroquine not able to prevent development of COVID-19, UMN trial shows

Today, University of Minnesota Medical School researchers published the results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19.

4 Jun 2020

Pandemic presents new hurdles, and hope, for people struggling with addiction

Before Philadelphia shut down to slow the spread of the coronavirus, Ed had a routine: most mornings he would head to a nearby McDonald’s to brush his teeth, wash his face and — when he had the money — buy a cup of coffee.

2 Jun 2020

Crucial ingredient from University of Kansas included in authorized COVID-19 drug

When the Food and Drug Administration issued an emergency-use authorization for the investigational pharmaceutical remdesivir to treat COVID-19 on May 1, in part it was due to pioneering work performed by pharmaceutical chemists at the University of Kansas School of Pharmacy in 1990.

1 Jun 2020

Reducing inflammation improves stroke recovery, may extend window for therapy

Reperfusion therapy, the gold standard for stroke treatment, helps restore blood flow after a stroke caused by a clot, preventing loss of brain tissue. However, only about 10% of stroke patients qualify, in part because of reperfusion therapy's narrow treatment window.

1 Jun 2020